ArticleNature medicine2026
Computable longitudinal patient journeys from structured and unstructured EHR data.
Article in Nature medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
Most electronic health record (EHR) data reside in unstructured text, recorded in encounters between healthcare providers and patients. These encounters capture symptom narratives, adverse effects, treatment rationales, adherence challenges, family history and other nuances that are not coded or only partially reflected in structured fields such as diagnosis and procedures codes. Yet the majority of real-world evidence studies rely on structured data fields. Here we present a new approach that uses large, pretrained language models to accurately extract computable clinical data from unstructured EHR text. Physician adjudication confirmed high accuracy against a blinded expert reference standard, with high expert physician inter-reviewer agreement. The framework is disease-agnostic and scales to large patient datasets across all clinical conditions. The extracted clinical entities are integrated with structured EHR data, embedded with medical ontologies, and organized into a knowledge graph, allowing all relationships between variables to be interrogated at the level of individual patients or at scale. An agentic-friendly programmatic interface navigates large-scale knowledge graph data, making analyses rapid, easy and cost-effective, both for exploration and hypothesis testing. This human-guided query environment enables acceleration of labor-intensive tasks, while study design, analytic decisions and interpretation remain under investigator control. To demonstrate clinical utility, we conducted a large-scale longitudinal analysis of treatment responses among individuals initiating glucagon-like peptide-1 receptor agonists (GLP-1 RAs) therapy. We identify large numbers of patients initiating GLP-1 RAs with high confidence, reconstruct patient-level trajectories, and model longitudinal changes in weight and hemoglobin A1c following GLP-1 RA initiation, revealing association between these parameters and response to therapy. Further, we characterize outcomes captured only in unstructured clinical notes and show time-to-event outcomes, moving beyond fixed-timepoint end points to provide a comprehensive understanding of real-world treatment responses.
Identifiers
42742184What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.